Search Results
Jul 07, 2026, 11:08 ET Fractal Selected as Preferred Services Partner in the Claude Partner Network
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Jul 07, 2026, 10:58 ET Fractal Selected as Preferred Services Partner in the Claude Partner Network
Qure.ai, a global healthcare AI leader focused on the rapid identification and management of tuberculosis, lung cancer, and stroke (or critical health conditions). Fractal's suite of businesses consists of Asper.ai (a
More news about: Fractal Analytics Limited
Jul 07, 2026, 09:43 ET Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
need."IPF is a chronic, progressive lung-scarring disease that disproportionately affects older adults. As fibrosis accumulates, lung tissue becomes stiff and scarred, making breathing increasingly difficult and leading to irreversible decline in lung function. The median survival after diagnosis
More news about: Insilico Medicine
Jul 07, 2026, 08:29 ET Accessia Health Opens Two New Financial Assistance Programs to Help Patients Manage Rising Healthcare Costs
conditions, announced the opening of two financial assistance programs for individuals living with asthma and non-small cell lung cancer. Eligible patients with non-small cell lung cancer may receive up to $4,000 in assistance, and those with asthma may receive up to $2,500, with travel expenses covered
More news about: Accessia Health
Jul 07, 2026, 08:17 ET VolitionRx Announces Data Showing the Prognostic Value of its Nu.Q® Cancer Test
https://doi.org/10.3390/biom130812552. Couraud S, et al Baseline values of circulating nucleosomes in Lung Cancer: NUCLEO-LUNG study. ELCC
More news about: VolitionRx Limited
Jul 07, 2026, 07:00 ET Altesa BioSciences Announces Upcoming Oral Presentation Featuring Novel Vapendavir Data at European Respiratory Society International Congress 2026
July 7, 2026 /PRNewswire/ -- Altesa BioSciences, a clinical-stage pharmaceutical company dedicated to improving the lives of people with chronic lung diseases, today announced that an abstract featuring new clinical data on vapendavir -- the company's investigational oral rhinovirus capsid inhibitor
More news about: Altesa Biosciences Inc.
Jul 07, 2026, 06:00 ET Legionnaires' Disease Lawyers Investigate New York City Upper East Side Legionnaires' Disease Outbreak
who inhale water vapor from Legionella-contaminated cooling towers can develop Legionnaires' disease. Especially if they are over 50 years old, have lung problems, have cancer, or are immunocompromised.Is Legionnaires' Disease Preventable?Yes, Legionnaires' disease is preventable.
More news about: The Lange Law Firm
Jul 06, 2026, 08:30 ET Anixa Biosciences and Moffitt Cancer Center Advance Ovarian Cancer CAR-T Clinical Trial to Highest Dose Level to Date
breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. These vaccine technologies focus on immunizing against "retired" proteins that have been found to be expressed in certain forms
More news about: Anixa Biosciences, Inc.
Jul 06, 2026, 08:11 ET IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
Brazilian physicians and institutions", commented IceCure CEO, Eyal Shamir "Commercial procedures are already being performed, including for breast, lung, kidney cancer and musculoskeletal tumors", Shamir continued.Leading experts in cryoablation such as Dr. José Hugo Luz, a member of the SOBRICE
More news about: IceCure Medical
Jul 06, 2026, 08:00 ET Matica Bio and VaxDome Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models
The project centers on VaxDome's unique approach to broad protection against diverse known / unknown viruses as well as lung cancer by rapid transformation of a selected influenza virus strain into a safe, intranasally delivered, antigen-agnostic antiviral / vaccine hybrid
More news about: Matica Biotechnology, Inc.
Jul 06, 2026, 07:05 ET TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH
Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the closing of its strategic investment in PAD Aviation, a premier Germany-based private aviation operator.
More news about: TransMedics Group, Inc.
Jul 02, 2026, 10:31 ET Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
mutations.What is Non-small Cell Lung Cancer?Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, accounting for approximately 85% of all lung cancer cases. It is a heterogeneous group of malignancies that originate from the epithelial cells of the lung and includes several histological
More news about: DelveInsight Business Research, LLP
Jul 02, 2026, 10:00 ET INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP
Monitoring Committee (IDMC) for the TACTI-004 Phase III study evaluating eftilagimod alfa ('efti') in patients in 1st line non-small cell lung cancer has recommended the discontinuation of the trial following a planned interim futility analysis in accordance with the study protocol." According
More news about: Pomerantz LLP
Jul 02, 2026, 06:30 ET Partner Therapeutics Announces Publication of Results From the eNRGy Trial of Zenocutuzumab in Patients with NRG1+ Cholangiocarcinoma in Journal of Clinical Oncology (JCO)
for Grade 4 or life-threatening IRR or hypersensitivity/anaphylaxis reactions.Interstitial Lung Disease/PneumonitisBIZENGRI can cause serious and life-threatening interstitial lung disease (ILD)/pneumonitis.In the eNRGy study, ILD/pneumonitis occurred in 2 (1.1%) patients treated
More news about: Partner Therapeutics, Inc.
Jul 02, 2026, 03:24 ET DJI Agriculture nâng tầm nông nghiệp chính xác với việc ra mắt toàn cầu Agras T55 và hệ thống phun pin kép T100
phun pin kép Agras T100 mang đến tính linh hoạt cao hơn trong nhiều nhiệm vụ nông nghiệp và cải thiện hiệu quả. Với hai pin thông minh, thời gian lơ lửng tăng 50% ở cùng mức tải trọng, trong khi dung tích bình chứa 90 lít bảo đảm thời lượng hoạt động dài hơn - cho phép vận hành liền mạch, không gián đoạn
More news about: DJI
Jul 02, 2026, 00:12 ET Fosun International Garners Five Awards from Corporate Governance Asia
first-line treatment of extensive-stage small cell lung cancer (ES-SCLC), and has been approved for marketing in over 40 countries and regions. HLX43 has shown significant advantages, with a favorable efficacy and safety profile in non-small cell lung cancer (NSCLC), gynecological tumors, esophageal squamous
More news about: Fosun
Jul 01, 2026, 21:00 ET Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
agreement with AstraZeneca (LSE/STO/NYSE: AZN) to jointly advance the clinical development of a novel IO-TKI combination therapy for non-small cell lung cancer (NSCLC). As a multicenter, open-label Phase I/II clinical study, the combination will evaluate the safety and efficacy of Abbisko's first-in-class
More news about: Abbisko
Jul 01, 2026, 10:00 ET BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES
for MediChip™ in the UAE - concentrating initially on colorectal cancer patients, with scope to subsequently branch out to other cancers (pancreatic, lung), and non-cancer indications.About Roswell ParkFrom the world's first chemotherapy research to the PSA prostate cancer biomarker,
More news about: BioSapien Inc
Jul 01, 2026, 09:00 ET Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
milestone.Idiopathic Pulmonary Fibrosis:A Phase II study evaluating ifetroban in patients with the most common form of progressive fibrosing interstitial lung disease is actively enrolling at medical centers across the U.S. Favorable interim safety findings have been announced and the next milestone is the
More news about: Cumberland Pharmaceuticals Inc.
Jul 01, 2026, 08:36 ET Cyclone Pods Publishes Raw, Sample-by-Sample Lab Data for Its Nicotine-Free Vapes and Pouches
Disease Control and Prevention as a chemical of concern in samples associated with the 2019 outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI); diacetyl is a flavoring compound that has been studied for respiratory effects in occupational settings.Cyclone Pods' vapes —
More news about: Cyclone Pods
Jul 01, 2026, 08:17 ET "I Have Decided to Marry Peru": Keiko Fujimori in an Exclusive Interview with Ismael Cala
Family's Final ReconciliationThe emotional climax of the interview centered on Susana Higuchi's final days after being diagnosed with aggressive lung cancer. While she was in intensive care, doctors observed that her body continued resisting in ways they could not medically explain, suggesting that
More news about: Cala Enterprises Corporation
Jul 01, 2026, 08:00 ET Lung Denervation Trial targets Novel COPD Phenotype
company's proprietary dNerva® Lung Denervation System addresses airway hyper-responsiveness, a pathophysiologic underpinning of both COPD and asthma, with a one-time, outpatient procedure designed to improve lung function, exacerbation rates and quality of life.The dNerva® lung denervation system is under
More news about: Nuvaira, Inc.
Jul 01, 2026, 08:00 ET Oncologists Say Cancer Care Starts Too Late - PreOncology™ Launches New Medical Specialty Focused on Finding Cancer Before Stage I
de-identified patient records derived from many of the same large prospective research studies that underpin national cancer screening guidelines. For lung cancer alone, the model incorporates data from more than 611,000 individuals, substantially expanding the evidence base available for individualized
More news about: PreOncology
Jul 01, 2026, 06:04 ET World Bronchiectasis Day: 3 Things to Know About the Irreversible Lung Disease that Impacts 500,000 People in the U.S.
Lung.org/bronchiectasis.About the American Lung AssociationThe American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic
More news about: American Lung Association
Jun 30, 2026, 08:00 ET Many Pet Owners May Be Underestimating Heartworm Risk, New Claims Data Shows
mosquito and can affect both dogs and cats. Once infected, worms can live in the heart, lungs, and associated blood vessels, potentially leading to severe lung disease, heart failure, organ damage, and, in some cases, death. Because symptoms may not appear until the disease has progressed, routine testing and
More news about: Embrace Pet Insurance